What happened this week? Boston Pharmaceuticals, Biosimilars, Adaptimmune

28/11/2015 - 1 minute

Monday: First Investment by the Former CEO of Sanofi? Just a €560M Virtual Biotech… #Easy

Tuesday: 2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?

 

Wednesday: Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!

Thursday: A €1.3M Start-Up is Engineering Baker’s Yeast to Make Green House Gases Useful

Friday: Could this new TCR Lung Cancer Trial Save Adaptimmune from a Volatile Stock Situation?

 

 

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!